Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Innovative Pharmaceutical Biotech ( (HK:0399) ).
Starcoin Group Limited has announced a board meeting scheduled for November 28, 2025, to consider and approve the consolidated interim results for the six months ending September 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting stakeholders and market positioning.
More about Innovative Pharmaceutical Biotech
Starcoin Group Limited, formerly known as Innovative Pharmaceutical Biotech Limited, operates in the pharmaceutical and biotechnology industry. The company is incorporated in the Cayman Islands and continued in Bermuda with limited liability, focusing on innovative pharmaceutical products and services.
Average Trading Volume: 21,249,869
Technical Sentiment Signal: Sell
Current Market Cap: HK$137.1M
For detailed information about 0399 stock, go to TipRanks’ Stock Analysis page.